id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-P-1065-0009,FDA,FDA-2014-P-1065,Letter from FDA CDER to Zydus Pharmaceuticals,Supporting & Related Material,Background Material,2015-03-10T04:00:00Z,2015,3,,,2015-03-10T20:16:09Z,,0,0,0900006481a39c2c
FDA-2014-P-1065-0008,FDA,FDA-2014-P-1065,Letter from Zydus Pharmaceuticals to FDA,Other,Letter(s),2015-03-10T04:00:00Z,2015,3,2015-03-10T04:00:00Z,,2015-03-10T20:10:19Z,,0,0,0900006481a39e02